The Economic Burden of Dialysis Patients in Belgium: a Comparison Between Haemo and Peritoneal Dialysis

- Authors: Max Dratwa1, Anne Marie Bogaert2, Koen Bouman3, Xavier Warling4, Remi Hombrouckx5, Mario Schurgers6, Pierre Dupont7, Anne Vereerstraeten8, Guy Van Roost9, Karin Caekelbergh10, Mark Lamotte11, Suzanne Laplante12
-
View Affiliations Hide Affiliations1 CHU Brugmann, Brussels, Belgium 2 AZ Sint Elisabeth, Zottegem, Belgium 3 ZNA, Middelheim, Antwerp, Belgium 4 Center Hospital Régionale Citadelle, Liège, Belgium 5 AZ Zusters van Barmhartigheid, Ronse, Belgium 6 AZ St. Jan, Brugge, Belgium 7 CHU Tivoli, La Louvière, Belgium 8 CHU André Vésale, Montigny-Le-Tilleul 9 St. Jan Hospital Brussels, Belgium 10 Health Economics and Outcomes Research, IMS Health, Brussels, Belgium 11 Health Economics and Outcomes Research, IMS Health, Brussels, Belgium 12 Baxter Healthcare Corporation, Baxter World Trade SA/NV, Belgium
- Source: Outcomes Assessment in End - Stage Kidney Disease - Measurements and Applications in Clinical Practice , pp 208-222
- Publication Date: October 2013
- Language: English


The Economic Burden of Dialysis Patients in Belgium: a Comparison Between Haemo and Peritoneal Dialysis, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781608057351/chapter-12-1.gif
The number of patients on dialysis has increased by about 50% in the past decade in Belgium. This growth is expected to continue, albeit at a slower pace, due to the ageing of the population and the increased prevalence of hypertension and diabetes, two of the main causes of end-stage kidney disease. The aim of this study was to assess the economic burden (i.e., dialysis procedure; hospitalizations; ambulatory care; medications; transport) to the public healthcare payer of patients undergoing dialysis in Belgium. Records of 130 Belgian patients on dialysis in 2006 were retrospectively reviewed to identify direct medical and non-medical resources used over a year. Official tariffs were used to cost the resources. Considering the prevalence of each dialysis modality in Belgium, the average cost of a dialysis patient was found to be 70,649 per year (haemodialysis: 72,350; peritoneal dialysis: 55,343). The dialysis procedure itself was the main cost driver (66% of all costs) followed by hospitalizations and ambulatory care (16% of all costs each). The dialysis procedure per se was 27% more expensive, while hospital and ambulatory services were respectively 28% and 45% more expensive for haemodialysis than peritoneal dialysis patients. Considering that there were 6,607 patients on dialysis in Belgium (0.06% of the Belgian population) at the end of 2006, it is estimated that the economic burden to the Belgian healthcare system was 467 million Euro or 2.45% of the healthcare budget. This study provides further evidence that home modalities, such as peritoneal dialysis, could help reduce the economic burden of dialysis on the healthcare budget.
-
From This Site
/content/books/9781608057351.chapter-12dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
